Skip to main content

Sequenom Shares Up 5.5 Percent on Breast Cancer Metastasis Findings

NEW YORK, May 23 (GenomeWeb News) - Shares in Sequenom were up more than 5.5 percent at $.95 in afternoon trading today after the company said its scientists have identified a link between the intracellular adhesion molecule gene ICAM1 and breast cancer metastasis.


According to Sequenom, the researchers found that the level of ICAM1 protein expression in the cell surface positively correlates with metastatic potential of several human breast cancer cell lines, and that ICAM1 mRNA levels were elevated in breast cancer tumor tissue versus normal tissue.


The researchers also found that ICAM1 down-regulation at the mRNA and protein level led to a strong suppression of human breast cell invasion, the company said.


The findings were published in today's issue of Carcinogenesis.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.